Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All Insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Secondary marketplace / Trade private companies / Buy and sell BioIntellisense stock
BioIntellisense

BioIntellisense stock

Highest bid
$XXXX
x/xx/xx
Lowest ask
$XXXX
x/xx/xx
Last matched price
$XXXX
x/xx/xx
$--
Register to buy and sell private company shares
For more details on private stock price information, financing and valuation for BioIntellisense, register or log in.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Log In

BioIntellisense stock price

Trade metrics

Market activity 2
Limited
Active bids
XX
Active asks
XX
Highest bid price
$ XXX.XX
Lowest ask price
$ XXX.XX
Total bids
$XXX
Total asks
$XXX
Last matched price
$ XXX.XX
xx/xx/xxxx
Last matched valuation
$ XXX.XX
xx/xx/xxxx

Price history chart

7D
1M
3M
1Y
All
Forge Price
$--
Not yet available
Forge Price valuation
$--

Actively traded Healthcare companies

Active market

The image displayed is not current and any securities shown are for illustrative purposes only.

Forge exclusive fund offerings

Fund offerings
The image displayed is not current and any securities shown are for illustrative purposes only.
Forge exclusive fund offerings
Access high-growth companies at a fixed price—for a limited time
Invest in trending companies with lower minimums
Simplify private investing through a Forge-managed single company fund

BioIntellisense stock FAQs

To buy and sell BioIntellisense stock

Can you buy BioIntellisense stock?

As BioIntellisense is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private companies like BioIntellisense, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge to buy private market stock on our secondary marketplace. If you are not accredited, find out how to begin the process and qualify for new investment opportunities.

How to buy BioIntellisense stock?

To invest in a private company like BioIntellisense through Forge, you must first qualify as an accredited investor. Create your account. Verify your identity and accreditation status to access Forge’s real-time marketplace.

  1. Explore opportunities. Browse companies with active bids and asks, plus data-driven pricing insights like historical trades and Forge Price™.
  2. Submit or negotiate a bid. Place a bid or engage with existing asks—self-directed and fully transparent.
  3. Complete your trade. Forge handles paperwork and approvals, with settlement typically in 45-60 days.
If you’d like additional guidance, Forge private market specialists are available to help.

Can you sell BioIntellisense stock?

Yes, as a shareholder, you may be able to sell your BioIntellisense shares through Forge’s private market platform—subject to company policies and market interest.

To get started:

  1. Create a Forge account and complete identity and ownership verification.
  2. Submit a sell order (ask) by specifying your desired price, quantity and share class.
  3. Forge will work to match your order with interested buyers in the marketplace.
  4. If a match occurs, Forge coordinates the necessary company approvals and compliance checks, including any transfer restrictions or right of first refusal (ROFR) processes BioIntellisense may have in place.
Please note that the ability to complete a transaction depends on BioIntellisense’s secondary trading policies, available demand and transaction approvals. While liquidity is not guaranteed, listing your shares on Forge allows you to signal interest and potentially connect with qualified buyers.

How to sell BioIntellisense stock?

  1. Create a free Forge account to access Forge’s next generation marketplace
  2. Explore potential demand for your shares and view live market interest
  3. Use proprietary pricing insights and market data to assess timing and valuation
  4. Submit an indication to sell, negotiate terms, complete the transaction and receive your payment

To learn more about BioIntellisense stock

Is BioIntellisense a public company?

No, BioIntellisense is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is BioIntellisense’s stock price?

BioIntellisense is a privately held company and therefore does not have a public stock price. However, you may access BioIntellisense private market stock price with Forge Data.

What is BioIntellisense’s stock ticker symbol?

BioIntellisense does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

BioIntellisense funding rounds and valuation

Total funding $260.65MM

Funding history chart

Funding round details

Funding Date Share Class Amount Raised Price Per Share Post-Money Valuation 3 Key Investors
12/15/2022 Series B-1 $168.3MM $37.95 $1.18B Undisclosed Investors
Price Per Share
$37.95
Shares Outstanding
4,434,782
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
12/15/2022 Series B-1-1 $10.37MM $30.36 $1.18B Undisclosed Investors
Price Per Share
$30.36
Shares Outstanding
341,500
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
07/28/2021 Series B $44.99MM $37.95 $1.08B 7wire Technology Partners, Chimera, Fresenius Medical Care North America, James Murren, Mary Tolan, Pendrell Corporation, Royal Philips
Price Per Share
$37.95
Shares Outstanding
1,185,398
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wire Technology Partners, Chimera, Fresenius Medical Care North America, James Murren, Mary Tolan, Pendrell Corporation, Royal Philips
09/10/2020 Series A-1 $12MM $4.72 $107.68MM Undisclosed Investors
Price Per Share
$4.72
Shares Outstanding
2,540,939
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
07/09/2019 Series A $25MM $2.50 $62.49MM Cu Healthcare Innovation Fund, Tripletree Holdings, Uchealth
Price Per Share
$2.50
Shares Outstanding
9,999,066
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cu Healthcare Innovation Fund, Tripletree Holdings, Uchealth

Company details

BioIntelliSense is a provider of continuous health monitoring and clinical intelligence solutions for Remote Patient Monitoring (RPM) and developer of a medical-grade Data-as-a-Service (DaaS) platform designed to seamlessly capturesminute-to-minute vital signs, physiological biometrics and symptomatic events through an effortless patient experience.
Founded
2018
Headquarters
Golden, CO, United States

BioIntellisense news and media highlights

BioIntelliSense and UC Davis partner to remotely monitor oncology patients

BioIntelliSense has announced a continuation of its partnership with UC Davis Health, launching an in-hospital monitoring initiative for patients in need of bone marrow transplants and hematology/oncology services. Using the BioButton wearable device, the programme continuously monitors patients' vital signs, alerting clinicians to subtle shifts that may indicate potential deterioration, enabling faster, more proactive intervention. Early studies have shown that the BioButton improves clinical management of oncology patients. The companies plan to expand the initiative from in-hospital to at-home monitoring.

Dr. Jim Mault, founder and CEO of BioIntelliSense, on VatorNews podcast

BioIntelliSense CEO, Dr. Jim Mault, spoke on VatorNews podcast about the company's wearable device, BioButton, that offers continuous physiological monitoring of vital signs. He noted the device's evolution from a consumer wearable to a medical-grade product. The BioButton is designed to help address the shortage of healthcare workers by automating vital sign measurements, thereby reducing the need for bedside checks by nurses.
Browse More Insights

Other companies like BioIntellisense in the Digital Health sector

Sector: Healthcare
Subsector: Digital Health
Trade Metrics Last Funding Round
Company Forge Price Last Matched Price Share Class Post-Money Valuation 3 Price Per Share Amount Raised
BetterUpBetterUp--$xx.xxSeries E$4.75B$5.77$340MM
CalmCalm--$xx.xxSeries 1$404.67MM$2.38$25.07MM
Function HealthFunction Health--$xx.xxSeries A-5$2.68B$88.22$208.37MM
Included HealthIncluded Health--$xx.xxSeries E$1.13B$3.22$103.04MM
Modern HealthModern Health--$xx.xxSeries D$1.17B$44.05$74MM
NoomNoom--$xx.xxSeries F$3.66B$60.34$525.46MM
OURAOURA--$xx.xx--------
RoRo--$xx.xxSeries D-1$7.19B$15.33$100MM
TalkiatryTalkiatry--$xx.xx--------
ZocDocZocDoc$5.00 -$1.33 (21.01%)$xx.xxSeries D-2$2.62B$29.29$100MM

Forge is your trusted partner to buy and sell BioIntellisense stock

Forge is the trusted platform for buying and selling private company stock. Investors and shareholders worldwide rely on our deep data insights, liquidity solutions, and tailored investment opportunities to navigate the private market. Register to get started.

Updated on: Jul 16, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. Most active companies are companies with a high market activity with the highest post-money valuation in the same sector.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.